News And Announcements
AstraZeneca gets US approval for additional Imfinzi dosing option
AstraZeneca announced on Friday that ‘Imfinzi’, or durvalumab, has been approved in the US for an additional dosing option - a 1,500mg fixed dose every four weeks in the approved indications of unresectable stage-3 non-small cell lung cancer after chemoradiation therapy, and previously-treated advanced bladder cancer.
Segro gets approval for secondary listing on Euronext Paris
Property investment and development company Segro said on Friday that it has received approval for a secondary listing on Euronext Paris as it looks to maintain an efficient holding structure at end of the Brexit transition period.
Sage lifts dividend as recurring revenue rises 8.5%
Accounting software firm Sage lifted its dividend as it reported a 8. 5% rise in organic recurring revenue to £1. 6bn, driven by growth from existing and new customers, in North America and Northern Europe.
Unite buys new 800-bed development in Paddington from Travis Perkins
Student accommodation manager and developer Unite Group said on Friday that it has bought a new 800-bed development site in Paddington, central London, from Travis Perkins.
Hochschild reinstates dividend, cuts cost estimate
Hochschild Mining reinstated its dividend and said operating costs in the current financial year would be lower than previous guidance.